Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Venous Thrombosis

Free Subscription Articles published in Circulation Retrieve available abstracts of 17 articles: HTML format

Single Articles

March 2023
1. LASSEN MCH, Modin D, Skaarup KG, Johansen ND, et al
   Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection.
   Circulation. 2023;147:843-845.
   PubMed    
   
   
   January 2023
2. GOLDBERG JB, Giri J, Kobayashi T, Ruel M, et al
   Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Association.
   Circulation. 2023 Jan 23. doi: 10.1161/CIR.0000000000001117.
   PubMed     Abstract available
   
   
   September 2022
3. THIBORD F, Klarin D, Brody JA, Chen MH, et al
   Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.
   Circulation. 2022 Sep 26:101161CIRCULATIONAHA122059675.
   PubMed     Abstract available
   
   
   June 2022
4. POGOSOVA N, Bosch J, Bhatt DL, Fox KAA, et al
   Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.
   Circulation. 2022;145:1875-1877.
   PubMed    
   
   
   April 2022
5. PARK DW, Ahn JM, Kang DY, Kim KW, et al
   Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial.
   Circulation. 2022 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.059512.
   PubMed     Abstract available
   
   
   March 2022
6. STEVENS H, Canovas R, Tran H, Peter K, et al
   Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19-Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study.
   Circulation. 2022;145:940-942.
   PubMed    
   
   
   November 2021
7. NAEIJE R
   Letter by Naeije Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
   Circulation. 2021;144:e328-e329.
   PubMed    
   
   
   
8. HOWDEN EJ, Ruiz-Carmona S, La Gerche A, Delcroix M, et al
   Response by Howden et al to Letter Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
   Circulation. 2021;144:e330-e331.
   PubMed    
   
   
   August 2021
9. AN ZY, Peng D, Shi YJ
   A Patient With Acute Shortness of Breath and Inferior ST-Segment Elevation: A Diagnostic Trap.
   Circulation. 2021;144:577-579.
   PubMed    
   
   
   May 2021
10. ROBERT-EBADI H, Robin P, Hugli O, Verschuren F, et al
    Impact of the Age-Adjusted D-Dimer Cutoff to Exclude Pulmonary Embolism: A Multinational Prospective Real-Life Study (the RELAX-PE Study).
    Circulation. 2021;143:1828-1830.
    PubMed    
    
    
    April 2021
11. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    PubMed     Abstract available
    
    
    March 2021
12. BUKHARI S, Barakat AF, Eisele YS, Nieves R, et al
    Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.
    Circulation. 2021;143:1335-1337.
    PubMed    
    
    
    February 2021
13. 
    Correction to: Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
    Circulation. 2021;143:e249.
    PubMed    
    
    
    November 2020
14. PACKARD CJ
    Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Tr
    Circulation. 2020;142:e333-e334.
    PubMed    
    
    
    
15. SCHWARTZ GG, Szarek M, Bittner VA, Steg PG, et al
    Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Ran
    Circulation. 2020;142:e335-e336.
    PubMed    
    
    
    October 2020
16. MARSTON NA, Ruff CT, Sabatine MS
    Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
    Circulation. 2020;142:e264.
    PubMed    
    
    
    
17. QI Z, Sun A, Ge J
    Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
    Circulation. 2020;142:e262-e263.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: